譬ェ蠑丈シ夂、セ譌・譛ャ蜍慕黄鬮伜コヲ蛹サ逋ゅそ繝ウ繧ソ繝シ

6039 株式会社日本動物高度医療センター

Personal Services · Growth

PRICE: ¥991 · MKT CAP: ¥13.5B · P/E: 15.4x · P/B: 2.62x · DIV YIELD: 0.7%

PRICE — 5Y

Characteristics & Business Summary

Japan Animal Referral Medical Center Co., Ltd., together with its subsidiaries, owns and operates animal hospitals that provide advanced medical treatment for dogs and cats in Japan. The company's medical centers consist of cardiology, respiratory, urology...

Income Statement Highlights (¥ Million, except EPS/DPS in ¥)

Fiscal Period	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	Forecast
Net Sales	2,848	2,979	3,873	4,270	5,278	6,192	6,600
Operating Profit	406	439	581	497	721	1,150	1,270
Ordinary Profit	411	439	534	490	720	1,142	—
Net Profit	285	287	381	337	521	833	890
EPS	¥120	¥123	¥139	¥125	¥191	¥61	¥69
DPS	¥0	¥0	¥0	¥20	¥37	¥0	¥13

Balance Sheet & Valuation Highlights

Total Assets ¥11B

Net Assets (Equity) ¥5B

Equity Ratio 43.1%

ROE (Return on Equity) 17.1%

Cash & Equivalents ¥2B

Interest-Bearing Debt ¥5B

Capital Expenditure (CapEx) ¥2B

Depreciation & Amort. ¥1B

Major Shareholders

1. MSIP CLIENT SECURITIES 15.4%
2. KCPエクイティアシスト1号投資事業有限責任組合 11.7%
3. Japan Custody Bank 5.1%
4. 風越建設株式会社 4.4%
5. 平尾秀博 3.3%
6. サンリツサービス株式会社 3.1%
7. Nippon Life Insurance 3.0%
8. ヨシダトモヒロ 2.4%
9. 松永悟 1.5%
10. Ueda Yagi Tanshi Co., Ltd. 1.4%

Activist Activity

Mizuho Trust & Banking Co., Ltd. 5.46%

2026-05-12 · change

Pilgrim Partners Asia (Pte.) Ltd. 6.85%

2026-04-17 · change

Pilgrim Partners Asia (Pte.) Ltd. 7.89%

2026-01-30 · change

Mizuho Trust & Banking Co., Ltd. 7.72%

2026-01-22 · change

Pilgrim Partners Asia (Pte.) Ltd. 9.13%

2025-12-26 · change

Historical Per-Share Data & Valuation Ratios

Per Share Metric	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	Forecast
Revenues per share	¥1,196	¥1,280	¥1,416	¥1,585	¥1,937	¥455	¥484
FCF/Share	¥184	¥-19	¥30	¥-52	¥154	¥-70	—
EPS	¥120	¥123	¥139	¥125	¥191	¥61	¥69
DPS	¥0	¥0	¥0	¥20	¥37	¥0	¥13
Capital Spending per share	¥28	¥259	¥266	¥387	¥350	¥172	—
Book Value per share	¥981	¥1,079	¥1,355	¥1,415	¥1,523	¥358	—
Common Shares Outstanding	2M	2M	3M	3M	3M	14M	14M

Financial Aggregates & Margins

Financial Aggregate	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	Forecast
Revenues (Net Sales)	¥3B	¥3B	¥4B	¥4B	¥5B	¥6B	¥7B
Operating Margin (%)	14.2%	14.7%	15.0%	11.6%	13.7%	18.6%	19.2%
Net Profit (owners)	¥0B	¥0B	¥0B	¥0B	¥1B	¥1B	¥1B
Net Profit Margin (%)	10.0%	9.6%	9.8%	7.9%	9.9%	13.5%	13.5%
Working Capital	¥-2B	¥-3B	¥-2B	¥-3B	¥-3B	¥-4B	—
Total Debt (Interest-bearing)	¥3B	¥4B	¥4B	¥4B	¥3B	¥5B	—
Net Worth (Common Equity)	¥2B	¥3B	¥4B	¥4B	¥4B	¥5B	—
Return on Total Assets (ROA)	4.9%	4.1%	4.4%	3.8%	6.0%	7.4%	—
Return on Common Equity (ROE)	12.2%	11.4%	10.3%	8.8%	12.6%	17.1%	—

Business Summary & Analysis

Capital Strategy Targets

No active capital policy disclosure records found.